FDA Approves Combination Antibiotic Zerbaxa

Share this content:
FDA Approves Combination Antibiotic Zerbaxa
FDA Approves Combination Antibiotic Zerbaxa

TUESDAY, Dec. 23, 2014 (HealthDay News) -- The combination antibiotic Zerbaxa (ceftolozane/tazobactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated intra-abdominal infections and complicated urinary tract infections.

The approval for intra-abdominal infections is for use of Zerbaxa in combination with another drug, metronidazole, the agency said in a news release. The approval for urinary tract infection includes pyelonephritis.

Zerbaxa is the fourth antibiotic to be FDA approved in 2014, following approval of Dalvance (dalbavancin), Sivextro (tedizolid), and Orbactiv (oritavancin).

The drug's label includes a warning about decreased effectiveness among people with renal impairment, the FDA said. The most common side effects reported during clinical testing included nausea, diarrhea, headache, and pyrexia.

Zerbaxa is marketed by Cubist Pharmaceuticals, based in Lexington, Mass.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

AAP: Congress Urged to Act to Prevent Firearm Deaths

AAP: Congress Urged to Act to Prevent Firearm ...

Following latest shooting, pediatricians join call for action to be taken to address firearm deaths, injury

Lung Cancer Incidence Higher for Young Women Than Young Men

Lung Cancer Incidence Higher for Young Women Than ...

Crossover in sex-specific rates among U.S. non-Hispanic whites born since 1965

E-Cigarette Flavoring Agent May Impair Airway Defense System

E-Cigarette Flavoring Agent May Impair Airway Defense System

Flavoring commonly used in e-cigarettes suppresses cilia beat frequency, lasting for 60 minutes

is free, fast, and customized just for you!

Already a member?

Sign In Now »